Icosagen Cell Factory OÜRegistered
Key figures
8 771 543 €−32,1%
Revenue 2025
+10,7%
Average annual growth 2019–2025
Ratios
2025−50,0%
Profit margin
−10,0%
EBITDA margin
36,7%
Equity ratio
2,4×
Current ratio
−31,1%
Return on equity
3237 €
Average gross salary
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q2 2026 | 3 951 657 € | 176 | 936 603 € |
| Q1 2026 | 4 171 962 € | 185 | 911 298 € |
| Q4 2025 | 2 917 425 € | 180 | 920 170 € |
| Q3 2025 | 2 995 432 € | 183 | 948 072 € |
| Q2 2025 | 2 949 098 € | 184 | 946 108 € |
| Q1 2025 | 4 591 710 € | 190 | 1 039 450 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Summary of financial statements2019–2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||
| Total current assets | 2 374 310 | 3 931 706 | 9 313 303 | 12 870 969 | 6 572 660 | 8 165 151 | 13 324 470 |
| Total non-current assets | 1 400 765 | 1 861 668 | 2 370 529 | 6 741 209 | 17 155 320 | 22 401 657 | 25 160 413 |
| Total assets | 3 775 075 | 5 793 374 | 11 683 832 | 19 612 178 | 23 727 980 | 30 566 808 | 38 484 883 |
| Balance sheet — liabilities and equity | |||||||
| Current liabilities | 899 155 | 1 163 024 | 1 919 486 | 3 453 448 | 5 663 753 | 4 504 353 | 5 535 535 |
| Non-current liabilities | 740 996 | 751 550 | 552 563 | 979 187 | 408 830 | 7 559 025 | 18 830 282 |
| Total liabilities | 1 640 151 | 1 914 574 | 2 472 049 | 4 432 635 | 6 072 583 | 12 063 378 | 24 365 817 |
| Share capital | 11 504 | 11 504 | 11 504 | 11 504 | 11 504 | 11 504 | 11 504 |
| Retained earnings of previous periods | 1 297 943 | 2 002 372 | 3 746 248 | 9 079 231 | 15 046 991 | 17 522 845 | 18 369 728 |
| Profit for the year | 704 429 | 1 743 876 | 5 332 983 | 5 967 760 | 2 475 854 | 848 033 | −4 384 364 |
| Reserves and other equity | 121 048 | 121 048 | 121 048 | 121 048 | 121 048 | 121 048 | 122 198 |
| Total equity | 2 134 924 | 3 878 800 | 9 211 783 | 15 179 543 | 17 655 397 | 18 503 430 | 14 119 066 |
| Income statement | |||||||
| Sales revenue | 4 767 928 | 6 679 291 | 11 485 743 | 13 677 072 | 13 347 905 | 12 916 070 | 8 771 543 |
| Operating profit | 728 698 | 1 796 836 | 5 300 125 | 5 942 204 | 2 593 167 | 1 143 258 | −3 803 823 |
| EBITDA | 1 185 583 | 2 062 036 | 5 744 150 | 6 839 720 | 4 396 775 | 3 449 949 | −877 959 |
| Profit before income tax | 704 429 | 1 743 876 | 5 332 983 | 5 967 760 | 2 475 854 | 848 033 | −4 384 364 |
| Profit for the reporting year | 704 429 | 1 743 876 | 5 332 983 | 5 967 760 | 2 475 854 | 848 033 | −4 384 364 |
| Labour costs | 1 505 973 | 1 971 039 | 2 759 561 | 4 599 321 | 6 327 544 | 8 087 793 | 8 913 982 |
| Depreciation of non-current assets | 456 885 | 265 200 | 444 025 | 897 516 | 1 803 608 | 2 306 691 | 2 925 864 |
| Other indicators | |||||||
| Employees | 44 | 50 | 67 | 102 | 134 | 167 | 182 |
| Calculated dividend | — | 0 | 0 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
CompanyPersonShareholderOther roleAdditional link
Related companies
Same activity — Research and development in natural sciences and engineering
Same address